🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

10 recruiting trials

for High-grade Serous Ovarian Carcinoma (HGSOC)

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types NCT07503808Phase 115 sites📍 Denver📍 Sarasota📍 Detroit IDEAYA Biosciences · Tests: IDE034 A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors. NCT06476808Phase 117 sites📍 Los Angeles📍 Los Angeles📍 Hackensack Bristol-Myers Squibb · Tests: BMS-986463 A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer NCT05902988Phase 1, Phase 214 sites📍 Los Angeles📍 Newport Beach📍 Aurora Volastra Therapeutics, Inc. · Tests: VLS-1488 MAintenance Therapy With Aromatase Inhibitor in Epithelial Ovarian Cancer (MATAO) NCT04111978Phase 353 sites📍 Graz📍 Graz📍 Innsbruck Swiss GO Trial Group · Tests: Letrozole 2.5mg, Placebo OV Precision: Study Examining the Benefit of a Tumor- and Patient-specific Cancer Therapy NCT06466382NA10 sites📍 Baden📍 Basel📍 Sankt Gallen Swiss GO Trial Group · Tests: Treatment recommendation by molecular tumorboard (mTB) based on tumor profiling, Carboplatin / Paclitaxel Chemotherapy Multi-layer Data to Improve Diagnosis, Predict Therapy Resistance and Suggest Targeted Therapies in HGSOC NCT04846933NA1 site📍 Turku Turku University Hospital · Tests: WGS and RNA sequencing, circulating tumor DNA (ctDNA), FDG PET/CT imaging A Study of Sigvotatug Vedotin in Advanced Solid Tumors NCT04389632Phase 1158 sites📍 Anchorage📍 Fayetteville📍 Rogers Seagen, a wholly owned subsidiary of Pfizer · Tests: sigvotatug vedotin, pembrolizumab, cisplatin, carboplatin Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan NCT05005403Phase 148 sites📍 Duarte📍 Irvine📍 Los Angeles AbbVie · Tests: Azirkitug, Budigalimab, Bevacizumab, Telisotuzumab Adizutecan Study of CryptiVax-1001 in Maintenance Setting for Advanced Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer NCT07665515Phase 110 sites📍 Cambridge📍 Edinburgh📍 Glasgow Epitopea Ltd · Tests: CryptiVax-1001 First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer NCT06799065Phase 1, Phase 211 sites📍 Aurora📍 Sarasota📍 Detroit Accent Therapeutics · Tests: ATX-295, ATX-295 and bevacizumab (or biosimilar)
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy